{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-22-001571","form_type":"8-K","ticker":"SRRK","cik":"0001727196","company_name":"Scholar Rock Holding Corp","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.901671+00:00","generated_at":"2026-06-22T01:37:54.250327+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Scholar Rock appoints Dr. Jing Marantz as CMO, grants 250,000-share option award","bullets":["Dr. Jing Marantz appointed CMO effective Nov 9, 2022; brings >20 yrs experience in neurology, oncology, rare diseases.","Base salary $465,000, annual bonus target 40% of base, and inducement stock option for 250,000 shares.","Option vests 25% on first anniversary, remainder quarterly over 3 years; subject to continuing service.","Prior roles include EVP/CBO at Krystal Biotech, SVP at Acceleron (Merck) and Alnylam; board member at Arcturus Therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-22-001571","json":"https://secwatch.observer/filing/0001157523-22-001571.json","markdown":"https://secwatch.observer/filing/0001157523-22-001571.md","text":"https://secwatch.observer/filing/0001157523-22-001571.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1727196/000115752322001571/0001157523-22-001571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1727196/000115752322001571/a52964704.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T01:37:54.250327+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"037bc8c5e3","claim":"Dr. Jing Marantz was appointed as Chief Medical Officer at Scholar Rock Holding Corp.","evidence_excerpt":"appointed Dr. Jing Marantz as Chief Medical Officer effective as of November 9, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1727196/000115752322001571/0001157523-22-001571-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}